TRS TriMas Corporation
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The company operates through Packaging and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Aarts Packaging, Intertech, Omega Plastics, and Rapak brands. The Specialty Products segment designs, manufactures, and distributes steel cylinders for use in transportation, storage, and dispensing of packaged and compressed gases under the Norris Cylinder brand. It sells its products through a direct sales force, third-party agents, and distributors. The company was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.…
Industry Peers
Packaging & ContainersKey Statistics
About TriMas (NASDAQ: TRS)
›
TriMas (NASDAQ: TRS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Packaging & Containers industry, part of the Consumer Cyclical sector, and reports about 2,500 employees.
The shares were at 37.72 USD on 19 November 2026, up 16.0% over 52 weeks. Its 52-week range is 30.43 USD to 45.42 USD: the price is 17.0% below the high and 24.0% above the low.
At a market capitalisation of 1.33B USD, it trades at 14.8 times trailing earnings and 18.2 times forward earnings. The median trailing P/E of its 17 largest Packaging & Containers peers is 19.3, a discount of 23% for TRS. It pays a dividend yielding 0.42% (it pays out 6% of its earnings), against a median of 2.68% among the dividend payers in that peer group.
TriMas reports return on equity of 17.0%, an operating margin of 5.1% and revenue up 7.7% year over year.
It holds more cash than debt, a net cash position of 722.19M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 45.00 USD is 19.3% above the current price. The next earnings report is expected on 25 February 2027.